A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours (Q36694292)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours |
scientific article published on June 2004 |
Statements
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours (English)
F M Wachters
H J M Groen
J G Maring
M Porro
H Dumez
A T van Oosterom
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference